R. Ellis

R. Ellis, S. Letendre, S. M. de Almeida, 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir

I. Grant, D. Clifford, R. Ellis, 2012, Journal of acquired immune deficiency syndromes.

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris

R. Ellis, T. Al-Harbi, Shahad A. Muammer, 2015, The American journal of case reports.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects

I. Grant, R. Heaton, D. Clifford, 2019, AIDS.

Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

B. Wilsey, R. Ellis, H. Sacks, 2015, The journal of pain : official journal of the American Pain Society.

A multimodal assessment of driving performance in HIV infection

I Grant, T J Rosenthal, I. Grant, 2004, Neurology.

Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.

Sunia A Trauger, Gary Siuzdak, Ewa Kalisiak, 2009, Journal of proteome research.

HIV Neurocognitive Diagnosis, Natural History, and Treatment

Xiong Jiang, R. Ellis, D. Moore, 2015 .

Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.

R. Heaton, R. Ellis, S. Letendre, 2020, Journal of acquired immune deficiency syndromes.

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment

D. Katzenstein, K. Marder, K. Tashima, 2007, Neurology.

Neurologic complications of HIV disease and their treatment.

B. Ances, R. Ellis, J. McCutchan, 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.

R. Haubrich, I. Grant, D. Clifford, 2011, The Journal of antimicrobial chemotherapy.

CNS Neurotoxicity of Antiretrovirals

R. Ellis, S. Letendre, Q. Ma, 2019, Journal of Neuroimmune Pharmacology.

CNS Neurotoxicity of Antiretrovirals

R. Ellis, S. Letendre, Q. Ma, 2019, Journal of Neuroimmune Pharmacology.

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk

I. Grant, R. Ellis, J. McCutchan, 2014, Psychiatry Research.

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

D. Richman, I. Grant, H. Günthard, 2005, Journal of Virology.

Valproic acid does not affect markers of human immunodeficiency virus disease progression

I. Grant, B. Ances, R. Ellis, 2006, Journal of NeuroVirology.

Lithium improves HIV-associated neurocognitive impairment

E. Masliah, I. Grant, R. Ellis, 2006, AIDS.

Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon γ-inducible Protein 10, Correlate With Higher Working Memory Deficits

F. Vaida, R. Ellis, S. Letendre, 2022, Journal of acquired immune deficiency syndromes.

Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection

E. Masliah, I. Grant, R. Ellis, 2017, AIDS.

Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

W. Bush, P. Jia, R. Ellis, 2019, Mitochondrion.

Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis

R. Ellis, L. Basova, Alexander Lindsey, 2021, Viruses.

Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments.

I. Grant, R. Heaton, R. Ellis, 2003, Journal of the International Neuropsychological Society : JINS.

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

I. Grant, R. Heaton, J. Connor, 2017, Journal of Neuroinflammation.

Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV

R. Heaton, R. Ellis, J. Routy, 2021, Viruses.

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence

I. Grant, R. Heaton, R. Ellis, 2012, AIDS care.

HIV Infection Is Associated with Attenuated Frontostriatal Intrinsic Connectivity: A Preliminary Study

Robert K. Heaton, Colm G. Connolly, Ronald J. Ellis, 2015, Journal of the International Neuropsychological Society.

Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice

Gregory G. Brown, M. Kaul, S. Lipton, 2015, European Neuropsychopharmacology.

Altered Functional Response to Risky Choice in HIV Infection

Colm G. Connolly, M. Paulus, A. Bischoff-Grethe, 2014, PloS one.

“Frontal systems” behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency

Gregory G. Brown, I. Grant, R. Heaton, 2014, Psychiatry Research.

Human Immunodeficiency Virus Infection Heightens Concurrent Risk of Functional Dependence in Persons With Long-Term Methamphetamine Use

I. Grant, R. Ellis, D. Moore, 2013, Journal of addiction medicine.

Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users

E. Masliah, I. Grant, R. Heaton, 2006, Neurology.

Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients

E. Masliah, I. Grant, R. Ellis, 2003, Journal of acquired immune deficiency syndromes.

Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

I. Grant, R. Ellis, S. Letendre, 2003, The Journal of infectious diseases.

HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil

R. Ellis, S. Letendre, A. Nath, 2021, Journal of NeuroVirology.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Molecular and pathologic insights from latent HIV-1 infection in the human brain

E. Masliah, I. Grant, R. Ellis, 2013, Neurology.

Implications of apathy for everyday functioning outcomes in persons living with HIV infection.

I. Grant, R. Ellis, T. Marcotte, 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Prior Methamphetamine Use Disorder History Does Not Impair Interoceptive Processing of Soft Touch in HIV Infection

M. Paulus, A. Bischoff-Grethe, I. Grant, 2021, Viruses.

Peripheral neuropathy in HIV: prevalence and risk factors

D. Clifford, R. Ellis, R. Bosch, 2011, AIDS.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection

R. Ellis, S. Gianella, S. Letendre, 2016, Journal of NeuroVirology.

Osteopontin is increased in HIV-associated dementia.

R. Ellis, T. Burdo, H. Fox, 2008, The Journal of infectious diseases.

A Haptoglobin Exon Copy Number Variant Associates With HIV-Associated Neurocognitive Impairment in European and African-Descent Populations

R. Ellis, S. Letendre, D. Franklin, 2021, Frontiers in Genetics.

Iron-regulatory genes are associated with Neuroimaging measures in HIV infection

C. Fennema-Notestine, R. Heaton, R. Ellis, 2019, Brain Imaging and Behavior.

Iron-regulatory genes are associated with Neuroimaging measures in HIV infection

C. Fennema-Notestine, I. Grant, R. Heaton, 2019, Brain Imaging and Behavior.

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

P. Jia, Quan Wang, R. Ellis, 2017, Fluids and Barriers of the CNS.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals

Terry L. Jernigan, Rebecca J. Theilmann, Michael J. Taylor, 2009, Journal of NeuroVirology.

Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

D. Richman, I. Grant, H. Günthard, 2006, Brain : a journal of neurology.

Nervous System Infections

R. Ellis, D. Croteau, Suzi Hong, 2014 .

Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV

R. Heaton, J. Connor, R. Ellis, 2021, Molecular Neurobiology.

Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru

R. Ellis, M. Cherner, C. Cárcamo, 2021, Frontiers in Neurology.

Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection

R. Ellis, F. Palella, B. Taiwo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART

I. Grant, R. Ellis, S. Gianella, 2015, Scientific Reports.

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

Anthony Gamst, Justin C McArthur, Ian Abramson, 2014, Neurology.

Synergistic Effects of HIV Infection and Older Age on Daily Functioning

I. Grant, R. Ellis, S. Woods, 2012, Journal of acquired immune deficiency syndromes.

Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus Performance-Based Assessment of Everyday Functioning

I. Grant, R. Heaton, D. Clifford, 2011, Journal of the International Neuropsychological Society.

Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings

I. Grant, R. Heaton, D. Clifford, 2012, The Clinical neuropsychologist.

Association of antiretroviral therapy with brain aging changes among HIV-infected adults

R. Ellis, S. Letendre, D. Moore, 2018, AIDS.

Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

F. Vaida, R. Ellis, S. Letendre, 2018, Journal of NeuroVirology.

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

T. Jernigan, E. Masliah, I. Grant, 2002, AIDS.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, R. Heaton, D. Clifford, 2012, Journal of NeuroVirology.

Estimating selection pressures on HIV‐1 using phylogenetic likelihood models

Sergei L. Kosakovsky Pond, D. Richman, S. Little, 2008, Statistics in medicine.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Sergei L. Kosakovsky Pond, D. Richman, I. Grant, 2012, Virology.

HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption

R. Kaul, C. Kovacs, T. Chun, 2020, Journal of Virology.

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

I. Grant, R. Heaton, R. Ellis, 1997, Annals of neurology.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Susan Morgello, David Clifford, Florin Vaida, 2011, AIDS.

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.

I. Grant, R. Heaton, R. Ellis, 2003, Archives of neurology.

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

I. Grant, R. Heaton, R. Ellis, 2002, Archives of neurology.

IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments

F. Vaida, R. Ellis, S. Letendre, 2021, Journal of Neuroimmunology.

Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

S. Frost, R. Ellis, J. McCutchan, 2003, The Journal of infectious diseases.

Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis

R. Ellis, S. M. Raboni, M. Muro, 2011, Clinical chemistry and laboratory medicine.

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

Michael J. Taylor, R. Heaton, R. Ellis, 2007, AIDS.

Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil

R. Heaton, R. Ellis, M. Pedroso, 2018, Journal of NeuroVirology.

Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy

F. Vaida, I. Grant, J. Keltner, 2015, Pain.

Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV

R. Ellis, K. Goodkin, J. Knox, 2023, Open forum infectious diseases.

Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood

I. Grant, R. Ellis, T. Marcotte, 2014, Journal of NeuroVirology.

Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life.

I. Grant, R. Ellis, S. Letendre, 2013, AIDS patient care and STDs.

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

F. Vaida, I. Grant, B. Ances, 2010, Archives of neurology.

Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV

R. Heaton, D. Clifford, R. Ellis, 2022, Journal of acquired immune deficiency syndromes.

Objective and subjective sleep measures are associated with neurocognition in aging adults with and without HIV

Christopher N. Kaufmann, R. Heaton, R. Ellis, 2020, The Clinical neuropsychologist.

Neurocognitive functioning predicts frailty index in HIV

D. Jeste, I. Grant, R. Ellis, 2018, Neurology.

HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders

Ajit S. Divakaruni, E. Masliah, I. Grant, 2016, Neurobiology of Disease.

Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B

F. Vaida, R. Ellis, S. Letendre, 2016, Journal of NeuroVirology.

HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging.

Richard B Buxton, Florin Vaida, F. Vaida, 2010, The Journal of infectious diseases.

COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings

R. Ellis, S. Letendre, M. Cherner, 2020, Psychiatry Research.

Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort.

R. Ellis, R. Bosch, M. Wilson, 2018, AIDS.

Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort.

R. Ellis, R. Bosch, M. Wilson, 2018, AIDS.

Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types

D. Richman, R. Ellis, S. Gianella, 2017, Journal of Clinical Microbiology.

Metabolic Syndrome and Neurocognitive Deficits in HIV Infection

Jessica L. Montoya, D. Jeste, R. Heaton, 2019, Journal of acquired immune deficiency syndromes.

Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus

R. Ellis, F. Palella, K. Robertson, 2019, Clinical Infectious Diseases.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

I. Grant, R. Heaton, D. Clifford, 2017, Journal of the International Neuropsychological Society.

The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.

Jessica L. Montoya, I. Grant, R. Heaton, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons

I. Grant, R. Heaton, R. Ellis, 2015, Journal of NeuroVirology.

The Veterans Aging Cohort Study Index is Associated With Concurrent Risk for Neurocognitive Impairment

I. Grant, R. Ellis, S. Letendre, 2014, Journal of acquired immune deficiency syndromes.

Cerebrospinal Fluid (CSF) CD8+ T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND)

C. Spina, R. Ellis, S. Letendre, 2015, PloS one.

Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years

R. Heaton, D. Clifford, R. Ellis, 2022, Brain, behavior, & immunity - health.

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy

Konrad Scheffler, Ronald J. Ellis, Sergei L. Kosakovsky Pond, 2016, Virus evolution.

A neuropsychological investigation of multitasking in HIV infection: implications for everyday functioning.

I. Grant, R. Heaton, R. Ellis, 2011, Neuropsychology.

Sex Differences in the Patterns and Predictors of Cognitive Function in HIV

I. Grant, R. Heaton, R. Ellis, 2020, Frontiers in Neurology.

Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study

Zhongming Zhao, N. Schork, P. Jia, 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations

S. Little, R. Ellis, S. Gianella, 2017, PLoS pathogens.

HIV and antiretroviral therapy in the brain: neuronal injury and repair

Dianne Langford, E. Masliah, R. Ellis, 2008, Nature Reviews Neuroscience.

Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil

R. Heaton, R. Ellis, Davey M. Smith, 2013, Journal of NeuroVirology.

Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil

R. Heaton, R. Ellis, Davey M. Smith, 2013, Journal of NeuroVirology.

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

P. Satishchandra, R. Ownby, R. Ellis, 2011, Journal of NeuroVirology.

Cognitive changes in asymptomatic drug-naïve human immunodeficiency virus type 1 clade C infection

Shobini L. Rao, P. Satishchandra, R. Ellis, 2011, Journal of NeuroVirology.

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

Cassandra B. Jabara, C. Burch, R. Ellis, 2009, AIDS.

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

A. Gamst, I. Grant, R. Ellis, 2000, Neurology.

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer

E. Masliah, I. Grant, R. Ellis, 2013, Journal of NeuroVirology.

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States

H. Uno, R. Ellis, S. Letendre, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

F. Vaida, C. Fennema-Notestine, R. Heaton, 2017, The Journal of infectious diseases.

The prevalence and incidence of neurocognitive impairment in the HAART era

Justin C McArthur, Thomas D Parsons, Ronald J Bosch, 2007, AIDS.

Soluble CD14 is subtype-dependent in serum but not in cerebrospinal fluid in people with HIV

F. Vaida, R. Ellis, S. Letendre, 2022, Journal of Neuroimmunology.

Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301

S. Lipton, Linda Chang, R. Ellis, 2010, HIV clinical trials.

Dementia and neurocognitive disorders due to HIV-1 infection.

B. Ances, R. Ellis, Ronald J Ellis, 2007, Seminars in neurology.

Clinical validation of the NeuroScreen

C. Yiannoutsos, D. Clifford, L. Moo, 2005, Journal of NeuroVirology.

Neurocytoskeleton proteins in cerebrospinal fluid of people with HIV-1 subtypes B and C.

F. Vaida, R. Ellis, S. Letendre, 2020, Journal of acquired immune deficiency syndromes.

Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape

R. Ellis, S. Letendre, A. Umlauf, 2020, Journal of NeuroVirology.

Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern

F. Vaida, R. Ellis, S. Letendre, 2019, Journal of NeuroVirology.

Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery

R. Heaton, R. Ellis, M. Cherner, 2017, Journal of acquired immune deficiency syndromes.

Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization—case study

R. Ellis, S. Letendre, Davey M. Smith, 2017, Journal of NeuroVirology.

Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort

I. Grant, R. Heaton, D. Clifford, 2013, Journal of acquired immune deficiency syndromes.

Molecular epidemiology of HIV-1 clades in Southern Brazil.

R. Ellis, D. Rosario, M. Riedel, 2010, Memorias do Instituto Oswaldo Cruz.

HIV protease inhibitor exposure predicts cerebral small vessel disease

E. Masliah, I. Grant, R. Ellis, 2014, AIDS.

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection

C. Yiannoutsos, M. Max, D. Clifford, 1998, Neurology.

Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals

D. Fuchs, A. Winston, R. Ellis, 2016, International journal of tryptophan research : IJTR.

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

I. Grant, B. Ances, R. Heaton, 2012, Neurology.

Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk.

Jue Lin, I. Grant, R. Heaton, 2021, Drug and alcohol dependence.

Depression is associated with hippocampal volume loss in adults with HIV

Xiong Jiang, R. Ellis, D. Moore, 2021, Human brain mapping.

The impacts of HIV infection, age, and education on functional brain networks in adults with HIV

Xiong Jiang, R. Ellis, Shiva Hassanzadeh-Behbahani, 2022, Journal of NeuroVirology.

Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV

D. Jeste, R. Ellis, D. Moore, 2019, Journal of NeuroVirology.

Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV

M. Stein, R. Heaton, R. Ellis, 2021, Journal of NeuroVirology.

Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults

C. Depp, D. Jeste, R. Ellis, 2018, Behavioral medicine.

Physical exercise is associated with less neurocognitive impairment among HIV-infected adults

I. Grant, R. Ellis, D. Moore, 2013, Journal of NeuroVirology.

Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV.

D. Jeste, R. Ellis, S. Letendre, 2019, The Journal of the Association of Nurses in AIDS Care : JANAC.

Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV

R. Heaton, D. Clifford, R. Ellis, 2020, Brain, behavior, & immunity - health.

Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy

Jessica L. Montoya, D. Jeste, R. Ellis, 2019, Journal of acquired immune deficiency syndromes.

Relevance of glutamate levels in the CSF of patients with HIV-1–associated dementia complex

R. Heaton, R. Ellis, A. Basile, 1999, Neurology.

Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV

M. Stein, I. Grant, R. Heaton, 2021, Journal of NeuroVirology.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

I. Grant, D. Clifford, R. Ellis, 2013, The Journal of antimicrobial chemotherapy.

Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy.

A. Simmons, F. Vaida, I. Grant, 2021, Pain medicine.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

F. Vaida, I. Grant, D. Clifford, 2019, The lancet. HIV.

Reduced gut microbiome diversity in people with HIV who have distal neuropathic pain.

R. Heaton, R. Ellis, S. Gianella, 2021, The journal of pain.

HIV in the cART era and the mitochondrial: immune interface in the CNS.

R. Ellis, J. Fields, 2019, International review of neurobiology.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER

I. Grant, D. Clifford, M. Ritchie, 2012, Journal of NeuroVirology.

HIV and antiretroviral therapy: Impact on the central nervous system

R. Ellis, 2010, Progress in Neurobiology.

Gut microbiota dysbiosis is associated with worse emotional states in HIV infection

S. Peterson, I. Grant, R. Heaton, 2021, Journal of NeuroVirology.

Cannabis use is not associated with increased balance disturbances in HIV-infected individuals

R. Ellis, M. Cherner, D. Grelotti, 2021, Journal of Cannabis Research.

Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

F. Vaida, R. Ellis, J. Atkinson, 2009, Neuropsychopharmacology.

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

I. Grant, R. Ellis, J. McCutchan, 2011, Journal of NeuroVirology.

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

I. Grant, R. Heaton, R. Ellis, 2004, Annals of neurology.

Cognitive and neuronal link with inflammation: a longitudinal study in people with and without HIV infection.

K. Blennow, I. Grant, R. Heaton, 2020, Journal of acquired immune deficiency syndromes.

Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen

R. Ellis, R. Bosch, A. Collier, 2017, AIDS.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

R. Haubrich, F. Vaida, R. Heaton, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impacts of HIV infection, age, and education on functional brain networks in adults with HIV

Xiong Jiang, R. Ellis, D. Moore, 2022, Journal of NeuroVirology.

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals

Michael J. Taylor, M. Kaul, C. Yiannoutsos, 2011, Journal of NeuroVirology.

Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life

R. Ellis, S. Woods, S. Tierney, 2018, Journal of NeuroVirology.

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

R. Heaton, R. Ellis, J. McCutchan, 2010, BMC neurology.

Altered P‐Glycoprotein Expression in AIDS Patients with HIV Encephalitis

E. Masliah, R. Ellis, D. Langford, 2004, Journal of neuropathology and experimental neurology.

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

R. Ellis, S. Letendre, D. Lazzaretto, 2005, Journal of Neuroimmunology.

The impact of HIV-related neuropsychological dysfunction on driving behavior

Michael J. Taylor, I Grant, M. Taylor, 2000, Journal of the International Neuropsychological Society.

The impact of HIV-related neuropsychological dysfunction on driving behavior

Michael J. Taylor, I. Grant, R. Heaton, 1999, Journal of the International Neuropsychological Society.

Abstracts from the 12th International Symposium on NeuroVirology

I. Grant, R. Paul, R. Heaton, 2013, Journal of NeuroVirology.

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

E. Masliah, I. Grant, R. Ellis, 2011, Journal of NeuroVirology.

HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau

R. Ellis, B. Brew, S. Letendre, 2018, Journal of Neuroimmunology.

Minocycline treatment for HIV-associated cognitive impairment

D. Clifford, R. Ellis, M. Zink, 2011, Neurology.

Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale

I. Grant, R. Heaton, R. Ellis, 2008, Journal of clinical and experimental neuropsychology.

A battery approach for measuring neuropsychological change.

I. Grant, R. Heaton, R. Ellis, 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

A randomized clinical trial of CPI-1189 for HIV-associated cognitive–motor impairment

K. Marder, D. Clifford, M. Mcdermott, 2002, Neurology.

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings

I. Grant, R. Heaton, R. Ellis, 2004, AIDS.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults

I. Grant, R. Heaton, R. Ellis, 2004, Journal of Neuroimmunology.

Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy

Colm G. Connolly, Gregory G. Brown, M. Jenkinson, 2020, Journal of NeuroVirology.

The Effects of Low-Risk Drinking ON Neurocognition Among Older Persons Living with HIV as Compared to Those Without HIV.

R. Ellis, D. Moore, A. Umlauf, 2020, Alcoholism, clinical and experimental research.

Gait Speed Decline is Associated with Hemoglobin A1C, Neurocognitive Impairment, and Black Race in Persons with HIV.

R. Ellis, F. Palella, T. Brown, 2019, AIDS research and human retroviruses.

The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System

I. Grant, R. Heaton, D. Clifford, 2007, Journal of Neuroimmune Pharmacology.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

Jessica L. Montoya, D. Jeste, I. Grant, 2019, Journal of the International Neuropsychological Society.

Alterations of Brain Metabolites in Adults With HIV

J. VanMeter, Xiong Jiang, R. Ellis, 2021, Neurology.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study

R. Crum, I. Grant, D. Clifford, 2016, Journal of NeuroVirology.

Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study.

R. Heaton, D. Clifford, R. Ellis, 2022, Brain : a journal of neurology.

HIV peripheral neuropathy progression: protection with glucose-lowering drugs?

D. Clifford, R. Ellis, R. Bosch, 2012, Journal of NeuroVirology.

Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders

B. Ances, R. Ellis, S. Letendre, 2008, International review of psychiatry.

HIV-Infected Individuals with Co-occurring Bipolar Disorder Evidence Poor Antiretroviral and Psychiatric Medication Adherence

F. Vaida, I. Grant, R. Ellis, 2012, AIDS and Behavior.

Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIV

R. Heaton, R. Ellis, J. McCutchan, 2022, Journal of acquired immune deficiency syndromes.

Peripheral neuropathy in ART-experienced patients: prevalence and risk factors

D. Clifford, R. Ellis, R. Bosch, 2013, Journal of NeuroVirology.

Characteristics of motor dysfunction in longstanding HIV.

R. Ellis, D. Kolson, E. Singer, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Test–retest stability of calibrated BOLD-fMRI in HIV− and HIV+ subjects

Richard B. Buxton, Ronald Ellis, Beau M. Ances, 2011, NeuroImage.

HLA Gene Loci Associated with HIV Load in CSF and Blood Plasma in the CHARTER Cohort

F. Vaida, I. Grant, D. Clifford, 2014 .

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection

I. Grant, R. Ellis, S. Letendre, 2016, Pathogens & immunity.

Update and New Directions in Therapeutics for Neurological Complications of HIV Infections

R. Ellis, S. Letendre, 2016, Neurotherapeutics.

Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances

Jessica L. Montoya, D. Jeste, R. Ellis, 2020, Journal of NeuroVirology.

Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy

B. Ances, R. Ellis, J. McCutchan, 2011, AIDS.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

I. Grant, R. Heaton, J. Connor, 2018, Molecular Neurobiology.

Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation

I. Grant, R. Heaton, D. Clifford, 2015, Journal of acquired immune deficiency syndromes.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

I. Grant, R. Heaton, R. Ellis, 2005, AIDS.

Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

R. Ellis, K. Williams, T. Burdo, 2013, AIDS.

Increased glutamate in CSF and plasma of patients with HIV dementia.

R. Heaton, R. Ellis, A. Basile, 2002, Neurology.

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

Michael J. Taylor, D. Clifford, R. Ellis, 2011, AIDS.

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.

I. Grant, R. Ellis, J. McCutchan, 2001, AIDS.

Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B

F. Vaida, R. Ellis, S. Letendre, 2018, Journal of acquired immune deficiency syndromes.

A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults

Jessica L. Montoya, I. Grant, R. Ellis, 2016, AIDS and Behavior.

Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.

D. Richman, A. Gamst, I. Grant, 2009, Virology.

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

T. Jernigan, I. Grant, R. Ellis, 2001, Brain : a journal of neurology.

Incident major depressive episodes increase the severity and risk of apathy in HIV infection.

I. Grant, R. Heaton, R. Ellis, 2015, Journal of affective disorders.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

D. Clifford, R. Ellis, C. Marra, 2009, AIDS.

Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?

R. Ellis, S. Letendre, B. Best, 2009, The Netherlands journal of medicine.

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition

R. Heaton, R. Ellis, S. Letendre, 2023, Viruses.

Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV

R. Heaton, R. Ellis, S. Letendre, 2021, Journal of NeuroVirology.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, D. Murdock, R. Heaton, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Physical Activity Is Associated With Lower Odds of Cognitive Impairment in Women but Not Men Living With Human Immunodeficiency Virus Infection

R. Ellis, A. Ogunniyi, K. Robertson, 2018, The Journal of infectious diseases.

Frailty in the medically complex National NeuroAIDS Tissue Consortium (NNTC) cohort.

R. Ellis, D. Kolson, E. Singer, 2019, AIDS.

Frailty in the medically complex National NeuroAIDS Tissue Consortium (NNTC) cohort.

R. Ellis, D. Kolson, E. Singer, 2019, AIDS.

Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.

E. Masliah, I. Grant, R. Heaton, 2007, The Journal of infectious diseases.

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

I. Grant, D. Clifford, R. Ellis, 2008, Annals of neurology.

Role of metabolic syndrome components in HIV-associated sensory neuropathy

F. Vaida, I. Grant, B. Ances, 2009, AIDS (London).

Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy

Jessica L. Montoya, I. Grant, R. Ellis, 2017, Journal of acquired immune deficiency syndromes.

Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B

F. Vaida, R. Ellis, I. Abramson, 2023, Journal of NeuroVirology.

Erratum To: Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

Shobini L. Rao, P. Satishchandra, R. Ownby, 2007, Journal of NeuroVirology.

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

E. Masliah, I. Grant, R. Heaton, 2011, Journal of NeuroVirology.

Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection

L. Fellows, R. Heaton, N. Mayo, 2017, Journal of acquired immune deficiency syndromes.

Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection

I. Grant, S. Little, R. Ellis, 2013, Journal of NeuroVirology.

Polygenic networks in peripheral leukocytes indicate patterns associated with HIV infection and context-dependent effects of cannabis use

R. Ellis, M. Cherner, R. Milner, 2022, Brain, behavior, & immunity - health.

Low CD4 nadir exacerbates the impacts of APOE ε4 on functional connectivity and memory in adults with HIV.

Raymond Scott Turner, Xiong Jiang, R. Ellis, 2021, AIDS.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

Peripheral neuropathy in ART-experienced patients: prevalence and risk factors

D. Clifford, R. Ellis, R. Bosch, 2013, Journal of NeuroVirology.

Emotional health and its association with neurocognition in Hispanic and non-Hispanic White people with HIV.

R. Heaton, R. Ellis, D. Moore, 2023, Journal of the International Neuropsychological Society : JINS.

Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults

D. Jeste, I. Grant, R. Ellis, 2017, Journal of acquired immune deficiency syndromes.

Levels Are Associated With Neurocognitive Impairment in Older HIV plus Adults Permalink

D. Jeste, R. Ellis, S. Letendre, 2016 .

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

E. Masliah, I. Grant, R. Heaton, 2002, Neurology.

Script Generation of Activities of Daily Living in HIV-Associated Neurocognitive Disorders

I. Grant, R. Heaton, R. Ellis, 2011, Journal of the International Neuropsychological Society.

Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts

I. Grant, R. Heaton, D. Clifford, 2012 .

Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria

W. Blattner, L. Magder, I. Grant, 2019, Journal of acquired immune deficiency syndromes.

Title Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations Permalink

S. Little, R. Ellis, S. Gianella, 2016 .

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

Michael J. Taylor, Gregory G. Brown, T. Patterson, 2005, Journal of NeuroVirology.

Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia

I. Grant, R. Ellis, C. Achim, 2019, Neurobiology of Disease.

Diagnostic validity of the dementia questionnaire for Alzheimer disease.

D. Jeste, L. Thal, K. Lyons, 1998, Archives of neurology.

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV

R. Ellis, S. Letendre, Visesha Kakarla, 2023, International journal of molecular sciences.

Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV

I. Grant, R. Heaton, R. Ellis, 2020, AIDS and Behavior.

A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV

R. Heaton, R. Ellis, T. Marcotte, 2023, AIDS and Behavior.

CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

M. Bondi, R. Ellis, C. Achim, 2022, Journal of NeuroVirology.

CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

M. Bondi, R. Ellis, C. Achim, 2022, Journal of NeuroVirology.

Connectome-based prediction of global cognitive performance in people with HIV

Xiong Jiang, R. Ellis, D. Moore, 2021, NeuroImage: Clinical.

Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV

Austin D. Swafford, Kelly C. Weldon, Bryn C. Taylor, 2020, mSystems.

Better executive function is independently associated with full HIV suppression during combination therapy.

R. Heaton, R. Ellis, S. Letendre, 2019, AIDS.

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

Zhongming Zhao, P. Jia, I. Grant, 2017, Fluids and Barriers of the CNS.

The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons

I. Grant, R. Heaton, R. Ellis, 2016, Journal of NeuroVirology.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Zhongming Zhao, P. Jia, I. Grant, 2016, The Journal of infectious diseases.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

C. Fennema-Notestine, T. Jernigan, I. Grant, 2014, Journal of NeuroVirology.

Alterations in the Levels of Vesicular Trafficking Proteins Involved in HIV Replication in the Brains and CSF of Patients with HIV-associated Neurocognitive Disorders

E. Masliah, I. Grant, R. Ellis, 2013, Journal of Neuroimmune Pharmacology.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

W. Blattner, I. Grant, R. Ellis, 2012, Journal of NeuroVirology.

Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid

I. Grant, D. Clifford, R. Ellis, 2012, Antimicrobial Agents and Chemotherapy.

Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

W. Blattner, I. Grant, R. Ellis, 2012, Journal of NeuroVirology.

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function

M. Bondi, Douglas Galasko, R. Ellis, 2023, Viruses.

HIV-1 neurocognitive disorders and chemokine receptors.

I. Grant, R. Heaton, R. Ellis, 1997, AIDS (London).

Association of painful human immunodeficiency virus distal sensory polyneuropathy with aberrant expectation of pain relief: functional magnetic resonance imaging evidence

A. Simmons, J. Keltner, R. Ellis, 2021, Brain communications.

Risk of developing cerebral β-amyloid plaques with post-translational modification among HIV-infected adults.

R. Ellis, D. Moore, A. Umlauf, 2019, AIDS.

CD3+CD56+ and CD3−CD56+ lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C

F. Vaida, R. Ellis, I. Abramson, 2023, Journal of Neuroimmunology.

Role of metabolic syndrome components in human immunodeficiency virus-associated stroke

F. Vaida, I. Grant, B. Ances, 2009, Journal of NeuroVirology.

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning

E. Masliah, I. Grant, R. Heaton, 2016, HIV/AIDS.

Update and New Directions in Therapeutics for Neurological Complications of HIV Infections

R. Ellis, S. Letendre, 2016, Neurotherapeutics.

Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection

R. Heaton, R. Ellis, J. Barnholtz-Sloan, 2019, Journal of acquired immune deficiency syndromes.

Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV

Kalen J. Petersen, R. Ellis, J. McCutchan, 2023, Brain, behavior, & immunity - health.

Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus

R. Ellis, D. Kolson, E. Singer, 2019, Clinical Infectious Diseases.

MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology

W. ElShamy, R. Ellis, M. Cherner, 2023, Viruses.

Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection.

R. Ellis, S. Letendre, D. Rosario, 2019, Journal of immunological methods.

Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach

R. Ellis, C. Achim, E. Sundermann, 2023, Research square.

Astrocyte Activation is A Potential Mechanism Underlying Depressed Mood and Apathy in People with HIV

R. Ellis, S. Letendre, Johnny J. He, 2022, Journal of neurology and psychology.

Antiretroviral therapy reduces neurodegeneration in HIV infection

E. Masliah, I. Grant, R. Ellis, 2015, AIDS.

Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090

D. Clifford, R. Ellis, C. Marra, 2007, HIV clinical trials.

Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape

R. Ellis, S. Letendre, A. Umlauf, 2020, Journal of NeuroVirology.

Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil.

R. Ellis, T. Marcotte, M. Cherner, 2013, Journal of affective disorders.

Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.

D. Richman, S. Frost, R. Ellis, 2009, Virology.

Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study

F. Vaida, I. Grant, R. Ellis, 2021, Journal of acquired immune deficiency syndromes.

Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy

F. Vaida, K. Blennow, I. Grant, 2021, Journal of Neuroimmunology.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND

F. Vaida, C. Fennema-Notestine, I. Grant, 2016, Journal of NeuroVirology.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, I. Grant, R. Heaton, 2012, Journal of NeuroVirology.

F. Vaida, I. Grant, J. Keltner, 2012, Psychosomatics.

Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV

R. Heaton, R. Ellis, S. Letendre, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings

I. Grant, R. Heaton, R. Ellis, 2011, Journal of NeuroVirology.

Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1

F. Vaida, I. Grant, D. Clifford, 2010, Antimicrobial Agents and Chemotherapy.

Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.

R. Heaton, R. Ellis, S. Letendre, 2020, Journal of acquired immune deficiency syndromes.

Baseline 10-year cardiovascular risk scores predict cognitive function in older persons, and particularly women, living with HIV infection.

R. D'Agostino, J. Massaro, R. Ellis, 2020, Clinical Infectious Diseases.

Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis

R. Ellis, S. Gianella, S. Letendre, 2019, Journal of NeuroVirology.

Memantine for AIDS dementia complex

S. Lipton, Linda Chang, R. Ellis, 2010 .

Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS

R. Haubrich, R. Heaton, R. Ellis, 2007, Journal of Neuroimmune Pharmacology.

Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy

R. Ellis, F. Palella, B. Taiwo, 2017, The Journal of infectious diseases.

Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics

R. Ellis, S. Letendre, Davey M. Smith, 2018, Journal of NeuroVirology.

Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues

R. Ellis, S. Gianella, C. Ignacio, 2023, Journal of virology.

Association Between VACS Index and Health-Related Quality of Life in Persons with HIV: Moderating Role of Fruit and Vegetable Consumption

Jessica L. Montoya, D. Jeste, R. Ellis, 2022, International Journal of Behavioral Medicine.

Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome

Austin D. Swafford, Carolina S. Carpenter, Kelly C. Weldon, 2023, Microorganisms.

Baseline neurocognitive impairment (NCI) is associated with incident frailty but baseline frailty does not predict incident NCI in older persons with HIV.

R. Ellis, F. Palella, N. Sacktor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy

R. Parker, R. Ellis, S. Letendre, 2020, The Journal of infectious diseases.

Subacute myoclonic measles encephalitis – An opportunistic HIV-associated infection

H. Vinters, R. Ellis, C. Achim, 2023, Frontiers in Cellular Neuroscience.

Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV

R. Heaton, D. Clifford, N. Calcutt, 2020, Annals of clinical and translational neurology.

Lamotrigine for HIV-associated painful sensory neuropathies

D. Clifford, R. Ellis, Y. So, 2003, Neurology.

Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis

R. Ellis, S. Gianella, S. Letendre, 2019, Journal of NeuroVirology.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

M. Lederman, C. Yiannoutsos, K. Marder, 1999, AIDS.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

F. Vaida, C. Fennema-Notestine, B. Ances, 2016, Journal of Neurovirology.

Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV

D. Clifford, R. Ellis, C. Marra, 2023, Viruses.

Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.

J. Keltner, R. Ellis, J. Atkinson, 2019, AIDS.

Effect of Cannabis Use on HIV DNA during Suppressive ART.

R. Ellis, S. Gianella, D. Franklin, 2019, Clinical Infectious Diseases.

Opioid blockade improves human recognition memory following physiological arousal

R. Ellis, A. Lincoln, D. W. Jacobs, 2001, Pharmacology Biochemistry and Behavior.

CD3+CD56+ and CD3−CD56+ lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C

F. Vaida, R. Ellis, I. Abramson, 2023, Journal of Neuroimmunology.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, R. Heaton, D. Clifford, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study

R. Crum, I. Grant, D. Clifford, 2016, Journal of NeuroVirology.

Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life

R. Ellis, S. Woods, S. Tierney, 2018, Journal of NeuroVirology.

Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir

I. Grant, D. Clifford, R. Ellis, 2012, Journal of acquired immune deficiency syndromes.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

D. Clifford, R. Ellis, C. Marra, 2009, AIDS.

HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau

R. Ellis, B. Brew, S. Letendre, 2018, Journal of Neuroimmunology.

Reply to Haddow et al.

F. Vaida, C. Fennema-Notestine, A. Gamst, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2010, Journal of NeuroVirology.

Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV

D. Jeste, R. Ellis, D. Moore, 2019, Journal of NeuroVirology.

Alterations in the Levels of Vesicular Trafficking Proteins Involved in HIV Replication in the Brains and CSF of Patients with HIV-associated Neurocognitive Disorders

E. Masliah, I. Grant, R. Ellis, 2013, Journal of Neuroimmune Pharmacology.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

I. Grant, R. Ellis, J. Carr, 2012, Journal of NeuroVirology.

Clinical factors related to brain structure in HIV: the CHARTER study

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2011, Journal of NeuroVirology.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2010, Neurology.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection

R. Ellis, S. Gianella, S. Letendre, 2015, Journal of NeuroVirology.

Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1

F. Vaida, I. Grant, D. Clifford, 2010, Antimicrobial Agents and Chemotherapy.

Neurologic complications of HIV disease and their treatment.

R. Ellis, S. Letendre, A. Mccutchan, 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

R. Heaton, R. Ellis, J. McCutchan, 2010, BMC neurology.

Human immunodeficiency virus and the central nervous system.

R. Ellis, S. Letendre, S. M. de Almeida, 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Better Biomarkers Are Needed to Improve the Management of the Neurologic Complications of HIV Infection

R. Ellis, J. McCutchan, S. Letendre, 2008 .